Sensitive nonradiometric method for determining thymidine kinase I activity

Clinical Chemistry

Volumn 50, Issue 9, 2004, Pages 1597-1606

  Öhrvik, Anders ^a   Lindh, Maria ^a   Einarsson, Roland ^a   Grassi, Jacques ^b   Eriksson, Staffan ^c  

^a Diasorin SpA   (Italy)

^b DIF   (France)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROPHILE ANTIBODY; HORSERADISH PEROXIDASE; POLYCLONAL ANTIBODY; THYMIDINE KINASE; THYMIDINE KINASE 1; THYMIDINE KINASE 2; TUMOR MARKER; UNCLASSIFIED DRUG; ZIDOVUDINE; ZIDOVUDINE 5' PHOSPHATE;

ARTICLE; CONTROLLED STUDY; CYTOSOL; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PHOSPHORYLATION; RADIOENZYMATIC ASSAY;

BREAST NEOPLASMS; FEMALE; HELA CELLS; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; THYMIDINE KINASE; THYMINE NUCLEOTIDES; TUMOR MARKERS, BIOLOGICAL; ZIDOVUDINE;

EID: 4344575831     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.030379     Document Type: Article

References (49)

1. Bradshaw HD Jr, Deininger PL. Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol Cell Biol 1984;4:2316-20.
2. Sherley JL, Kelly TJ. Regulation of human thymidine kinase during the cell cycle. J Biol Chem 1988;263:8350-8.
3. Sherley JL, Kelly TJ. Human cytosolic thymidine kinase. Purification and physical characterization of the enzyme from HeLa cells. J Biol Chem 1988;263:375-82.
4. Munch-Petersen B, Cloos G, Tyrsted G, Eriksson S. Diverging substrate specificity of pure human thymidine kinase 1 and 2 against antiviral dideoxy nucleosides. J Biol Chem 1991;266: 2032-8.
5. Eriksson S, Kierdaszuk B, Munch-Petersen B, Oberg B, Johansson NG. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun 1991;176:586-92.
6. Furman PA, Fyfe JA, St. Clair MH, Weinhold K, Rideout JL, Freeman GA, et al. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 1986;83:8333-7.
7. Hampton A, Chawla RR, Kappler F. Species or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes. J Med Chem 1982; 25:644-9.
8. Lunato AJ, Wang J, Woollard JE, Anisuzzaman AK, Ji W, Rong FG, et al. Synthesis of 5-(carboranylalkylmercapto)-2′-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2. J Med Chem 1999;42:3378-89.
9. He Q, Skog S, Welander I, Tribukait B. Enzyme kinetics of thymidine isoenzymes of Ehrlich ascites tumour cells. Cell Prolif 1991;24:3-14.
10. Kauffmann MG, Kelly TJ. Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis. Mol Cell Biol 1991;11: 2538-46.
11. Wintersberger E. Regulation and biological function of thymidine kinase [Review]. Biochem Soc Trans 1997;25:303-8.
12. Ke PY, Chang ZF. Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-Cdh1-mediated pathway. Mol Cell Biol 2004;24:514-26.
13. Wang L, Eriksson S. Cloning and characterization of full-length mouse thymidine kinase 2: the N-terminal sequence directs import of the precursor protein into mitochondria. Biochem J 2000;351:469-76.
14. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001;24:342-4.
15. Hallek M, Wanders L, Strohmeyer S, Emmerich B. Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications [Review]. Ann Hematol 1992;65:1-5.
16. Poley S, Stieber P, Nussler V, Pahl H, Fateh-Moghadam A. Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma. Anticancer Res 1997;17:3025-9.
17. Hallek M, Emmerich B, Noworousian MR, eds. Individual risk assessment for patients with haematological malignancies. A basis for optimized treatment strategies. Stuttgart: Georg Thieme Verlag, 1999:56pp.
18. Hallek M, Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Adorf D, et al. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood 1999;93:1732-7.
19. Di Raimondo F, Giustolisi R, Lerner S, Cacciola E, O'Brien S, Kantarjian H, et al. Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine. Ann Oncol 2001;12:621-5.
20. Romain S, Spyratos F, Descotes F, Daver A, Rostaing-Puissant B, Bougnoux P, et al. Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: a retrospective multicenter study. Int J Cancer 2000;87:860-8.
21. Broet P, Romain S, Daver A, Ricolleau G, Quillien V, Rallet A, et al. Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients. J Clin Oncol 2001;19: 2778-87.
22. Foekens JA, Romain S, Look MP, Martin PM, Klijn JG. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy. Cancer Res 2001;61: 1421-5.
23. He Q, Zou L, Zhang PA, Lui JX, Skog S, Fornander T. The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody. Int J Biol Markers 2000;15:139-46.
24. Wang N, He Q, Skog S, Eriksson S, Tribukait B. Investigation on cell proliferation with a new antibody against thymidine kinase 1. Anal Cell Pathol 2001;23:11-9.
25. Voeller DM, Parr A, Allegra CJ. Development of human anti-thymidine kinase antibodies. Anticancer Drugs 2001;12:555-9.
26. Kuroiwa N, Nakayama M, Fukuda T, Fukui H, Ohwada H, Hiwasa T, et al. Specific recognition of cytosolic thymidine kinase in the human lung tumor by monoclonal antibodies raised against recombinant human thymidine kinase [Review]. J Immunol Methods 2001;253:1-11.
27. Zhang F, Shao X, Li H, Robinson JG, Murray BK, O'Neill KL. A monoclonal antibody specific for human thymidine kinase 1. Hybridoma 2001;20:25-34.
28. Zhang F, Li H, Pendelton AR, Robinson JG, Monson KO, Murray BK, et al. Thymidine kinase 1 immunoassay: a potential marker for breast cancer. Cancer Detect Prev 2001;25:8-15.
29. Zou L, Zhang PG, Zou S, Li Y, He Q. The half-life of thymidine kinase 1 in serum measured by EC dot blot: a potential marker for monitoring the response to surgery of patients with gastric cancer. Int J Biol Markers 2002;17:135-40.
30. Öhrvik A, Lindh M, Davidsson I, Eriksson S, Einarsson R. A highly sensitive method for determination of thymidine kinase 1 (TK) activity [Abstract]. 15th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine Proceedings. Bologna, Italy: Euromedlab, Monduzzi, Editore 2003:747-52.
31. Wang J, Choudhury D, Chattopadhyaya J, Eriksson S. Stereoisomeric selectivity of human deoxyribonucleoside kinases. Biochemistry 1999;38:16993-9.
32. Gronowitz J, Källander C, Diderholm H, Hagberg H, Pettersson U. Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans. Int J Cancer 1984;33:5-12.
33. Goujon L, Brossette T, Dereudre-Brosquet N, Creminon C, Clayette P, Dormont D, et al. Monitoring of intracellular levels of 5′-monophosphate- AZT using an enzyme immunoassay. J Immunol Methods 1998;218:19-30.
34. Romain S, Spyratos F, Guirou O, Deytieux S, Chinot O, Martin PM. Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC receptor study group report. Eur J Cancer 1994;30:2163-5.
35. Wang L, Munch-Petersen B, Herrstrom Sjoberg A, Hellman U, Bergman T, Jornvall H, et al. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates. FEBS Lett 1999;443: 170-4.
36. Kennedy JW, Carey NR, Coolen RB, Garber CC, Lee HT Jr, Levine JB, et al. Evaluation of precision performance of clinical chemistry devices. NCCLS Approved Guideline EP5-A. Wayne, PA: NCCLS, 1999.
37. Kricka U. Human anti-animal antibody interferences in immunological assays [Review]. Clin Chem 1999;45:942-56.
38. Karlström AR, Neumüller M. Gronowitz JS, Källander CFR. Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA [Review]. Mol Cell Biochem 1990;92:23-35.
39. Tadepalli SM, Quinn RP. Determination of zidovudine concentrations in serum by enzyme-linked immunosorbent assay and by time-resolved fluoroimmunoassay. J AIDS 1990;3:19-27.
40. Shaw T, Smillie RH, MacPhee DG. The role of blood platelets in nucleoside metabolism: assay, cellular location and significance of thymidine phosphorylase in human blood [Review]. Mutat Res 1988;200:99-116.
41. el Kouni MH, el Kouni MM, Naguib FN. Differences in activities and substrate specificity of human and rnurine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines. Cancer Res 1993;53:3687-93.
42. Pauly JL, Schuller MG, Zelcer AA, Kriss TA, Gore SS, Germain MJ. Identification and comparative analysis of thymidine phosphorylase in plasma of healthy subjects and cancer patients. J Natl Cancer Inst 1977;58:1587-90.
43. Lavie A, Schlichting I, Vetter IR, Konrad M, Reinstein J, Goody RS. The bottleneck in AZT activation. Nat Med 1997;8:922-4.
44. Guettari N, Loubiere L, Brisson E, Klatzmann D. Use of herpes simplex virus thymidine kinase to improve the antiviral activity of zidovudine. Virology 1997;235:398-405.
45. Suzutani T, Koyano S, Saijo M, Chiba A, Azuma M. Analysis of non-sense mutants of varicella-zoster virus thymidine kinase. Arch Virol 1997;142:2059-64.
46. Arnér ESJ, Spasokoukotskaja T, Eriksson S. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues [Review]. Biochem Biophys Res Commun 1992;188:712-8.
47. Wang J, Su C, Neuhard J, Eriksson S. Expression of human mitochondrial thymidine kinase in Escherichia coli: correlation between the enzymatic activity of pyrimidine nucleoside analogues and their inhibitory effect on bacterial growth. Biochem Pharmacol 2000;59:1583-8.
48. Sander PH, Hanitsch S, Gehrke W, Öhrvik A, Mack M. Liaison TK1: development of a serum thymidine kinase assay for the use on the fully automated LIAISON random access analyzer [Abstract]. Clin Chem 2003;49(Suppl 6):A100.
49. Fujiwaki R, Hata K, Nakayama K, Moriyama M, Iwanari O, Katabu H, et al. Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes. Int J Cancer 2002; 99:328-35.